Haleos Labs share news, announcements and annual reports
NSE: HALEOSLABSBSE: 540679Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,429.20.
30 Oct: open ₹1,426.10, high ₹1,430.00, low ₹1,382.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹422 Cr1,954th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.68
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.11%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,40775.8% delivered
Haleos Labs share news and announcements
359 announcements, routine notices left out, newest first. Page 4 of 8.
Feb 2023
10 Feb · Results
Nov 2022
30 Nov · Rating
22 Nov · Related Party Transaction
Oct 2022
11 Oct · General updates
Sep 2022
26 Sep · General updates
8 Sep · Meeting
5 Sep · Corporate action
Aug 2022
30 Aug · General updates
25 Aug · Meeting
Jul 2022
25 Jul · Meeting
21 Jul · Disclosure of other UPSI/material event
20 Jul · Communication to shareholders as per Reg 30
Jun 2022
15 Jun · Disclosure
9 Jun · Related Party Transaction
May 2022
30 May · General updates
29 May · General updates
28 May · Results
7 May · Sale or disposal of unit/ division/subsidiary
Apr 2022
14 Apr · Disclosure of other UPSI/material event
12 Apr · Legal
The exchange asked on 11 Apr 2022
8 Apr · Disclosure of other UPSI/material event
Feb 2022
11 Feb · Board meeting
11 Feb · Results
Jan 2022
Dec 2021
29 Dec · Meeting
14 Dec · Business